Literature DB >> 29655382

Risk factors for influenza-related complications in children during the 2009/10 pandemic: a UK primary care cohort study using linked routinely collected data.

J J Lee1, C Bankhead1, M Smith1, A A Kousoulis2, C C Butler1, K Wang1.   

Abstract

Primary care clinicians have a central role in managing influenza/influenza-like illness (ILI) during influenza pandemics. This study identifies risk factors for influenza-related complications in children presenting with influenza/ILI in primary care. We conducted a cohort study using routinely collected linked data from the Clinical Practice Research Datalink on children aged 17 years and younger who presented with influenza/ILI during the 2009/10 pandemic. We calculated odds ratios (ORs) for potential risk factors in relation to influenza-related complications, complications requiring intervention, pneumonia, all-cause hospitalisation and hospitalisation due to influenza-related complications within 30 days of presentation. Analyses were adjusted for potential confounders including age, vaccination and socio-economic deprivation. Asthma was a risk factor for influenza-related complications (adjusted OR 1.48, 95% confidence interval (CI) 1.21-1.80, P < 0.001), complications requiring intervention (adjusted OR 1.44, 95% CI 1.11-1.88; P = 0.007), pneumonia (adjusted OR 1.64, 95% CI 1.07-2.51, P = 0.024) and hospitalisation due to influenza-related complications (adjusted OR 2.46, 95% CI 1.09-5.56, P = 0.031). Neurological conditions were risk factors for all-cause hospitalisation (adjusted OR 4.25, 95% CI 1.50-12.07, P = 0.007) but not influenza-related complications (adjusted OR 1.46, 95% CI 0.83-2.56, P = 0.189). Community-based early interventions to prevent influenza-related clinical deterioration should therefore be primarily targeted at children with asthma and neurological conditions.

Entities:  

Keywords:  Children; influenza; primary care; risk factors

Mesh:

Year:  2018        PMID: 29655382      PMCID: PMC9184939          DOI: 10.1017/S0950268818000353

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  25 in total

1.  Influenza vaccination in children with neurologic or neurodevelopmental disorders.

Authors:  Michael Smith; Georgina Peacock; Timothy M Uyeki; Cynthia Moore
Journal:  Vaccine       Date:  2015-03-30       Impact factor: 3.641

2.  Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the United Kingdom.

Authors:  C R Meier; P N Napalkov; Y Wegmüller; T Jefferson; H Jick
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-11       Impact factor: 3.267

3.  Outpatient antibiotic use in Europe and association with resistance: a cross-national database study.

Authors:  Herman Goossens; Matus Ferech; Robert Vander Stichele; Monique Elseviers
Journal:  Lancet       Date:  2005 Feb 12-18       Impact factor: 79.321

4.  Recording of Influenza-Like Illness in UK Primary Care 1995-2013: Cohort Study.

Authors:  Pia Hardelid; Greta Rait; Ruth Gilbert; Irene Petersen
Journal:  PLoS One       Date:  2015-09-21       Impact factor: 3.240

5.  Uptake of childhood influenza vaccine from 2012-2013 to 2014-2015 in the UK and the implications for high-risk children: a retrospective observational cohort study.

Authors:  Sankarasubramanian Rajaram; Amy Steffey; Betina Blak; Matthew Hickman; Hannah Christensen; Herve Caspard
Journal:  BMJ Open       Date:  2016-08-01       Impact factor: 2.692

6.  Should all acutely ill children in primary care be tested with point-of-care CRP: a cluster randomised trial.

Authors:  Jan Y Verbakel; Marieke B Lemiengre; Tine De Burghgraeve; An De Sutter; Bert Aertgeerts; Bethany Shinkins; Rafael Perera; David Mant; Ann Van den Bruel; Frank Buntinx
Journal:  BMC Med       Date:  2016-10-06       Impact factor: 8.775

7.  Data Resource Profile: Hospital Episode Statistics Admitted Patient Care (HES APC).

Authors:  Annie Herbert; Linda Wijlaars; Ania Zylbersztejn; David Cromwell; Pia Hardelid
Journal:  Int J Epidemiol       Date:  2017-08-01       Impact factor: 7.196

8.  Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2017-18 Influenza Season.

Authors:  Lisa A Grohskopf; Leslie Z Sokolow; Karen R Broder; Emmanuel B Walter; Joseph S Bresee; Alicia M Fry; Daniel B Jernigan
Journal:  MMWR Recomm Rep       Date:  2017-08-25

9.  Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised controlled trial.

Authors:  Nathan J Brendish; Ahalya K Malachira; Lawrence Armstrong; Rebecca Houghton; Sandra Aitken; Esther Nyimbili; Sean Ewings; Patrick J Lillie; Tristan W Clark
Journal:  Lancet Respir Med       Date:  2017-04-06       Impact factor: 30.700

10.  Access to the NHS by telephone and Internet during an influenza pandemic: an observational study.

Authors:  Paul Rutter; Oliver Mytton; Benjamin Ellis; Liam Donaldson
Journal:  BMJ Open       Date:  2014-02-03       Impact factor: 2.692

View more
  3 in total

Review 1.  "SPEECH": A literature based framework for the study of past epidemics.

Authors:  Antonis A Kousoulis; Imogen Grant
Journal:  J Infect Public Health       Date:  2022-01-19       Impact factor: 3.718

2.  Quality of life, healthcare use and costs in 'at-risk' children after early antibiotic treatment versus placebo for influenza-like illness: within-trial descriptive economic analyses of the ARCHIE randomised controlled trial.

Authors:  Ines Rombach; Kay Wang; Sharon Tonner; Jenna Grabey; Anthony Harnden; Jane Wolstenholme
Journal:  BMJ Open       Date:  2022-04-15       Impact factor: 3.006

3.  Serious outcomes of medically attended, laboratory-confirmed influenza illness among school-aged children with and without asthma, 2007-2018.

Authors:  Huong Q McLean; Kayla E Hanson; Allison D Foster; Scott C Olson; Sarah K Kemble; Edward A Belongia
Journal:  Influenza Other Respir Viruses       Date:  2020-01-14       Impact factor: 4.380

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.